It has been reported that the enzyme involved in the conversion of sphingomyelinase to ceramide, SMPDL3b, was decreased in renal biopsy samples of patients with focal segmental glomerulosclerosis (FSGS). This evidence concerns the gene SMPDL3B and focal segmental glomerulosclerosis.